This is a preprint.
Psilocybin-enhanced fear extinction linked to bidirectional modulation of cortical ensembles
- PMID: 38352491
- PMCID: PMC10862786
- DOI: 10.1101/2024.02.04.578811
Psilocybin-enhanced fear extinction linked to bidirectional modulation of cortical ensembles
Update in
-
Psilocybin-enhanced fear extinction linked to bidirectional modulation of cortical ensembles.Nat Neurosci. 2025 Jun;28(6):1311-1326. doi: 10.1038/s41593-025-01964-9. Epub 2025 May 26. Nat Neurosci. 2025. PMID: 40419686
Abstract
The serotonin 2 receptor (5HT2R) agonist psilocybin displays rapid and persistent therapeutic efficacy across neuropsychiatric disorders characterized by cognitive inflexibility. However, the impact of psilocybin on patterns of neural activity underlying sustained changes in behavioral flexibility has not been characterized. To test the hypothesis that psilocybin enhances behavioral flexibility by altering activity in cortical neural ensembles, we performed longitudinal single-cell calcium imaging in the retrosplenial cortex across a five-day trace fear learning and extinction assay. A single dose of psilocybin induced ensemble turnover between fear learning and extinction days while oppositely modulating activity in fear- and extinction- active neurons. The acute suppression of fear-active neurons and delayed recruitment of extinction-active neurons were predictive of psilocybin-enhanced fear extinction. A computational model revealed that acute inhibition of fear-active neurons by psilocybin is sufficient to explain its neural and behavioral effects days later. These results align with our hypothesis and introduce a new mechanism involving the suppression of fear-active populations in the retrosplenial cortex.
Conflict of interest statement
Declaration of competing interests. The authors declare no competing interests.
Figures
References
-
- Hoppen Thole H, Priebe Stefan, Vetter Inja, and Morina Nexhmedin. “Global Burden of Post-Traumatic Stress Disorder and Major Depression in Countries Affected by War between 1989 and 2019: A Systematic Review and Meta-Analysis.” BMJ Global Health 6, no. 7 (July 2021): e006303. 10.1136/bmjgh-2021-006303. - DOI - PMC - PubMed
-
- Agin-Liebes Gabrielle I, Malone Tara, Yalch Matthew M, Mennenga Sarah E, Ponté K Linnae, Guss Jeffrey, Bossis Anthony P, Grigsby Jim, Fischer Stacy, and Ross Stephen. “Long-Term Follow-up of Psilocybin-Assisted Psychotherapy for Psychiatric and Existential Distress in Patients with Life-Threatening Cancer.” Journal of Psychopharmacology 34, no. 2 (February 1, 2020): 155–66. 10.1177/0269881119897615. - DOI - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources